II
REGN icon

Inspire Investing’s Regeneron Pharmaceuticals REGN Stock Holding History

Inspire Investing’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-975
Closed -$672K – 759
2022
Q3 		$672K Sell
975
-952
-49% -$599K 0.09% 171
2022
Q2 		$1.14M Buy
1,927
+91
+5% +$59.2K 0.15% 122
2022
Q1 		$1.28M Buy
1,836
+168
+10% +$106K 0.15% 135
2021
Q4 		$1.05M Buy
1,668
+1,095
+191% +$673K 0.12% 160
2021
Q3 		$347K Sell
573
-7,170
-93% -$4.45M 0.04% 280
2021
Q2 		$4.33M Buy
7,743
+474
+7% +$240K 0.57% 31
2021
Q1 		$3.44M Buy
7,269
+2,308
+47% +$1.12M 0.53% 36
2020
Q4 		$2.4M Buy
4,961
+962
+24% +$519K 0.53% 28
2020
Q3 		$2.24M Sell
3,999
-355
-8% -$215K 0.62% 27
2020
Q2 		$2.72M Buy
4,354
+1,380
+46% +$783K 0.94% 15
2020
Q1 		$1.45M Sell
2,974
-939
-24% -$387K 0.58% 20
2019
Q4 		$1.47M Buy
3,913
+56
+1% +$18.8K 0.53% 32
2019
Q3 		$1.07M Buy
3,857
+216
+6% +$63.9K 0.41% 49
2019
Q2 		$1.14M Buy
3,641
+596
+20% +$198K 0.48% 34
2019
Q1 		$1.25M Buy
3,045
+751
+33% +$309K 0.58% 22
2018
Q4 		$857K Buy
2,294
+186
+9% +$68.1K 0.58% 23
2018
Q3 		$852K Buy
2,108
+239
+13% +$91K 0.53% 26
2018
Q2 		$645K Buy
1,869
+1,118
+149% +$350K 0.46% 33
2018
Q1 		$259K Buy
751
+245
+48% +$85.2K 0.26% 83
2017
Q4 		$190K Buy
+506
New +$205K 0.16% 89

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Inspire Investing's REGN Position: Q4 2022 in Review

Inspire Investing sold out of Regeneron Pharmaceuticals (REGN) in Q4 2022, closing a stake of 975 shares — an estimated $672K sold.

Inspire Investing first reported a position in REGN in Q4 2017 and held it in 20 quarters. The position peaked at $4.33M in Q2 2021. 1,158 funds tracked by Wall St. Rank hold REGN as of Q4 2022.

  • Inspire Investing reported no remaining Regeneron Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Inspire Investing sold 975 Regeneron Pharmaceuticals shares in Q4 2022, an estimated $672K.
  • Inspire Investing first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 20 quarters.
  • Inspire Investing's Regeneron Pharmaceuticals position peaked at $4.33M in Q2 2021.
  • 1,158 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2022.

Based on Inspire Investing's 13F filing for Q4 2022, filed 26 Jan 2023.